Home › Trial NCT03047980
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
- Trial IDNCT03047980
- StatusCompleted
- PhasePhase 2/3
- Study typeInterventional
- SponsorAnne Comi, MD
- Enrollment10
- Start date2017-01
- ConditionsSturge-Weber Syndrome
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.